Detalhe da pesquisa
1.
Novel Autoantibodies in Idiopathic Small Fiber Neuropathy.
Ann Neurol
; 91(1): 66-77, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34761434
2.
Expanding the genetic causes of small-fiber neuropathy: SCN genes and beyond.
Muscle Nerve
; 67(4): 259-271, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36448457
3.
Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors.
Cancer Immunol Immunother
; 71(11): 2583-2596, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35299256
4.
CD137 / CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases.
J Autoimmun
; 112: 102499, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32505443
5.
Induction of CD137 expression by viral genes reduces T cell costimulation.
J Cell Physiol
; 234(11): 21076-21088, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31025383
6.
The VCAM1-ApoE pathway directs microglial chemotaxis and alleviates Alzheimer's disease pathology.
Nat Aging
; 3(10): 1219-1236, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37735240
7.
Asymmetric limb weakness in Guillain-Barré syndrome: Three case reports.
World J Clin Cases
; 10(6): 1896-1902, 2022 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35317159
8.
Demographics and Medication Use of Patients with Late-Onset Alzheimer's Disease in Hong Kong.
J Alzheimers Dis
; 87(3): 1205-1213, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35466936
9.
An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer's disease.
Nat Aging
; 2(7): 616-634, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37117777
10.
Ectopic CD137 expression by rhabdomyosarcoma provides selection advantages but allows immunotherapeutic targeting.
Oncoimmunology
; 10(1): 1877459, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33643694
11.
Identification of CD137-Expressing B Cells in Multiple Sclerosis Which Secrete IL-6 Upon Engagement by CD137 Ligand.
Front Immunol
; 11: 571964, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33240262
12.
Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells.
Front Oncol
; 9: 945, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31616638
13.
Deletion of CD137 Ligand Exacerbates Renal and Cutaneous but Alleviates Cerebral Manifestations in Lupus.
Front Immunol
; 10: 1411, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31297111
14.
CD137L, a driver of harmful inflammation in the nervous system.
Neural Regen Res
; 18(11): 2387-2388, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37282461